BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdel-Aziz H, Kelber O, Lorkowski G, Storr M. Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast. Planta Med. 2017;83:1130-1140. [PMID: 28859216 DOI: 10.1055/s-0043-116852] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Houriet J, Arnold YE, Pellissier L, Kalia YN, Wolfender JL. Using Porcine Jejunum Ex Vivo to Study Absorption and Biotransformation of Natural Products in Plant Extracts: Pueraria lobata as a Case Study. Metabolites 2021;11:541. [PMID: 34436482 DOI: 10.3390/metabo11080541] [Reference Citation Analysis]
2 Houriet J, Allard PM, Queiroz EF, Marcourt L, Gaudry A, Vallin L, Li S, Lin Y, Wang R, Kuchta K, Wolfender JL. A Mass Spectrometry Based Metabolite Profiling Workflow for Selecting Abundant Specific Markers and Their Structurally Related Multi-Component Signatures in Traditional Chinese Medicine Multi-Herb Formulae. Front Pharmacol 2020;11:578346. [PMID: 33362543 DOI: 10.3389/fphar.2020.578346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Zielińska S, Jezierska-Domaradzka A, Wójciak-Kosior M, Sowa I, Junka A, Matkowski AM. Greater Celandine's Ups and Downs-21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today's Pharmacology. Front Pharmacol 2018;9:299. [PMID: 29713277 DOI: 10.3389/fphar.2018.00299] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
4 Périco LL, Rodrigues VP, Ohara R, Bueno G, Nunes VVA, dos Santos RC, Camargo ACL, Júnior LAJ, de Andrade SF, Steimbach VMB, da Silva LM, da Rocha LRM, Vilegas W, dos Santos C, Hiruma-Lima CA. Sex-specific effects of Eugenia punicifolia extract on gastric ulcer healing in rats. World J Gastroenterol 2018; 24(38): 4369-4383 [PMID: 30344421 DOI: 10.3748/wjg.v24.i38.4369] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mearin F, Malfertheiner P. Functional Gastrointestinal Disorders: Complex Treatments for Complex Pathophysiological Mechanisms. Dig Dis 2017;35 Suppl 1:1-4. [PMID: 29421797 DOI: 10.1159/000485407] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
6 Ulrich-Merzenich G, Welslau L, Aziz-Kalbhenn H, Kelber O, Shcherbakova A. Synergy quantifications to identify individual contributions of combination partners to the overall activity - The example of STW 5. Phytomedicine 2019;60:153013. [PMID: 31326154 DOI: 10.1016/j.phymed.2019.153013] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Allescher HD, Abdel-Aziz H. Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target. Dig Dis 2017;35 Suppl 1:18-24. [PMID: 29421789 DOI: 10.1159/000485456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Holtmann G, Schrenk D, Madisch A, Allescher HD, Ulrich-Merzenich G, Mearin F, Larrey D, Malfertheiner P. Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches. Dig Dis 2020;38:269-79. [PMID: 31770769 DOI: 10.1159/000504570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kelber O, Bauer R, Kubelka W. Phytotherapy in Functional Gastrointestinal Disorders. Dig Dis 2018;35:36-42. [DOI: 10.1159/000485489] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
10 Piccione M, Facchinello N, Schrenk S, Gasparella M, Pathak S, Ammar RM, Rabini S, Dalla Valle L, Di Liddo R. STW 5 Herbal Preparation Modulates Wnt3a and Claudin 1 Gene Expression in Zebrafish IBS-like Model. Pharmaceuticals (Basel) 2021;14:1234. [PMID: 34959635 DOI: 10.3390/ph14121234] [Reference Citation Analysis]